Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial
-
* Corresponding author: Robert D Sanders robert.sanders@ic.ac.uk
Critical Care 2010, 14:R38 doi:10.1186/cc8916
See related commentary by Kress, http://ccforum.com/content/14/3/164 and related letter by Quintin, http://ccforum.com/content/14/4/429
No comments have yet been made on this article.